Institute of Clinical and Molecular Virology

GRK 2504: Enhancing immunogenicity of Human T-cell leukaemia virus Type 1 (HTLV-1) by interfering with viral transcription (A2) (GRK 2504 A2) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028 Aufklärung der Virus-Wirt Interaktion zur Inhibition der Transmission des Humanen T-Zell-Leukämievirus Typ 1 (HTLV-1) Nov. 1, 2017 - April 30, 2026 A094: Host cell factors and nonstructural proteins of SARS-CoV-2 July 1, 2023 - Dec. 31, 2025 Milk Transmission of Viruses: Prevention of mother to child transmission of Human T-cell leukemia Virus Type 1 (HTLV-1) (Milk-TV) Nov. 1, 2020 - Oct. 31, 2025 Interferenz mit der Spaltung des viralen Proteins p12: Auswirkungen auf Transmission und Persistenz des onkogenen Retrovirus Humanes T-Zell-Leukämie-Virus Typ 1 (VI-Pfleger-Stiftung_virale Protein p12) Aug. 1, 2024 - July 31, 2025 A095: The 2’-O-methylation of viral RNA regulates innate immune sensing by MDA5 Jan. 1, 2023 - June 30, 2025 A096: Molecular and functional analysis of immune/ intestinal epithelial cell-interaction during CMV infection Jan. 1, 2023 - June 30, 2025 J100: A TRM-inducing mucosal vaccination against lung-metastasizing cancer Jan. 1, 2023 - June 30, 2025 P099: Influence of the translocated microbiome on the TCR repertoire April 16, 2022 - Jan. 15, 2024 Identification of host restriction factors against Human T-cell leukemia virus (BFHZ_Mobilitätsbeih._ER-Montpellier) Aug. 5, 2014 - Dec. 31, 2023